Examining Diversity in COVID-19 Clinical Trials Webinar

10/2/2020

webinar graphic

Finding a safe and effective treatment for COVID-19 remains a top priority for policymakers in the U.S. As the nation comes closer to a vaccine, many individuals have volunteered to join clinical trials. However, racial and ethnic minority groups have been underrepresented in these trials. During this webinar, hear from experts on how clinical trials operate, current COVID-19 clinical trials and efforts to include broader demographics in the research.

VIEW WEBINAR

VIEW WEBINAR AS PDF

Speakers:
  • George Mensah, MD, director, Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), NIH
  • Badhri Srinivasan, head of global development operations, Novartis

Additional Resources